Stonepine Capital Management’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-508,266
| Closed | -$204K | – | 59 |
|
|
2025
Q1 | $204K | Sell |
508,266
-191,734
| -27% | -$76.8K | 0.2% | 47 |
|
|
2024
Q4 | $673K | Buy |
700,000
+90,554
| +15% | +$87.1K | 0.54% | 36 |
|
|
2024
Q3 | $878K | Hold |
609,446
| – | – | 0.55% | 27 |
|
|
2024
Q2 | $737K | Buy |
609,446
+467,898
| +331% | +$566K | 0.67% | 17 |
|
|
2024
Q1 | $333K | Buy |
+141,548
| New | +$333K | 0.26% | 17 |
|
|
2020
Q1 | – | Sell |
-11,682
| Closed | -$122K | – | 28 |
|
|
2019
Q4 | $122K | Buy |
+11,682
| New | +$122K | 0.09% | 22 |
|